Frontlight ResearchEarly access
Lung cancer trials in Vietnam
10 of 15 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleOsimertinib Plus Stereotactic Radiosurgery/Radiotherapy for EGFR-Mutant Non-Small Cell Lung Cancer With Symptomatic Brain Metastases
- Where
- Ho Chi Minh City
- Age
- 18 years and over
- People
- 41
- Run by
- Cho Ray Hospital
See details and how to joinNCT07911449 - Phase 3Taking peoplePhase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
- Where
- Hanoi, Ho Chi Minh City, Vinh
- Age
- 18 years and over
- People
- 400 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07291037 · EU 2024-520101-39-00 - Phase 3Not yet taking people in VietnamDAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
- Where
- Hanoi, Ho Chi Minh City
- Age
- 18 years and over
- People
- 670 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07472517 · EU 2025-520565-51-00 - Phase 3Active, not recruitingSacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
- Where
- Hanoi, Hà Nội, Ho Chi Minh, Ho Chi Minh City
- Age
- 18 years and over
- People
- 614 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06170788 · EU 2023-503376-24-00 - Phase 3Taking peopleA Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
- Where
- Can Tho, Hanoi, Ho Chi Minh City, Vinh
- Age
- 18 years and over
- People
- 1,160 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06692738 · EU 2024-514281-39-00 - Phase 3Taking peoplePhase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
- Where
- Da Nang, Hanoi, Hà Nội, Ho Chi Minh City, Huế, Vinh, Vĩnh Yên
- Age
- 18 years and over
- People
- 675 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06357533 · EU 2023-505077-32-00 - Phase 3Taking peopleA Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
- Where
- Can Tho, Hanoi, Ho Chi Minh City, Vinh
- Age
- 18 years and over
- People
- 1,160 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06627647 · EU 2024-515008-38-00 - No phaseTaking peopleIntermittent Erector Spinae Plane Block Via Subcutaneous Port for Cancer Pain
- Where
- Hanoi
- Age
- 18 years and over
- People
- 180
- Run by
- Hanoi Medical University
See details and how to joinNCT07396558 - No phaseTaking peopleEffectiveness of Chat-based Mobile Application for Consultation (Zalo) in Improving Compliance With Follow-up Tests After Abnormal Chest X-ray Findings Interpret by Artificial Intelligent
- Where
- Ho Chi Minh City
- Age
- 40 years to 62 years
- People
- 2,692
- Run by
- Gia Dinh People Hospital
See details and how to joinNCT07234929 - Phase 3Active, not recruitingPhase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
- Where
- Hanoi, Hà Nội, Ho Chi Minh City, Vinh
- Age
- 18 years and over
- People
- 582 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06350097 · EU 2023-509883-89-00